Rationale
To ensure that quality medicines are available to the populace.
Aim and Objective
To provide a new perspective for drug sampling and testing using a risk‐based approach globally, and provide a reference for improving the efficiency of the drug sampling and testing programme in China.
Method
This study used a combination of theoretical analysis and problem analysis. First, we analysed the high‐risk drugs that should be given attention to theoretically in the drug sampling testing programme based on the healthcare reform in China. Second, this study leveraged on data on the sampling and testing of drugs extracted from self‐constructed data by the China Food and Drug Administration (CFDA). The integrated and structured data sets were used to conduct an innovative analysis that identifies the actual content of the drug sampling and testing programme and contrasts them with the theoretical content to understand the problems. This study used quantitative and qualitative approaches for data analysis.
Results
Following analysis, we discovered that there is still a big gap between the reality of drug sampling and testing in China and the ideal state of the objective requirements of healthcare reforms. The major sources of risk are the retail pharmacies or hospital pharmacies in the distribution chain of drugs; however, the CFDA sampled mostly drugs from drug manufacturers. Additionally, the CFDA did not sample adequate essential medicines, bid‐winning drugs (especially those with large price drops in centralized procurement), biological products and other high‐risk drug varieties. The high‐risk drugs produced by companies or enterprises with a history of noncompliance, especially bid‐winning enterprises in centralized procurement, were not sampled.
Conclusion
We suggest that the major content of drug sampling and testing in China should focus on the link of drug utilization, varieties of drugs with large price drops in centralized procurement and bid‐winning enterprises with a history of noncompliance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.